Translation and Validation of the Boston Technical Performance Score in a Developing Country

Carregando...
Imagem de Miniatura
Citações na Scopus
3
Tipo de produção
article
Data de publicação
2021
Título da Revista
ISSN da Revista
Título do Volume
Editora
SOC BRASIL CIRURGIA CARDIOVASC
Citação
BRAZILIAN JOURNAL OF CARDIOVASCULAR SURGERY, v.36, n.5, p.589-598, 2021
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
Introduction: The Technical Performance Score (TPS) was developed and subsequently refined at the Boston Children's Hospital. Our objective was to translate and validate its application in a developing country. Methods: The score was translated into the Portuguese language and approved by the TPS authors. Subsequently, we studied 1,030 surgeries from June 2018 to October 2020. TPS could not be assigned in 58 surgeries, and these were excluded. Surgical risk score was evaluated using Risk Adjustment in Congenital Heart Surgery (or RACHS-1). The impact of TPS on outcomes was studied using multivariable linear and logistic regression adjusting for important perioperative covariates. Results: Median age and weight were 2.2 (interquartile range [IQR] = 0.5-13) years and 10.8 (IQR = 5.6-40) kilograms, respectively. In-hospital mortality was 6.58% (n=64), and postoperative complications occurred in 19.7% (n=192) of the cases. TPS was categorized as 1 in 359 cases (37%), 2 in 464 (47.7%), and 3 in 149 (15.3%). Multivariable analysis identified TPS class 3 as a predictor of longer hospital stay (coefficient: 6.6; standard error: 2.2; P=0.003), higher number of complications (odds ratio [OR]: 1.84; 95% confidence interval [CI]: 1.1-3; P=0.01), and higher mortality (OR: 3.2; 95% CI: 1.4-7; P=0.004). Conclusion: TPS translated into the Portuguese language was validated and showed to be able to predict higher mortality, complication rate, and prolonged postoperative hospital stay in a high-volume Latin-American congenital heart surgery program. TPS is generalizable and can be used as an outcome assessment tool in resource diverse settings.
Palavras-chave
Cardiac Surgical Procedures, Risk Adjustment, Congenital Heart Surgery, Hospital Mortality, Postoperative Period, Reference Standards
Referências
  1. Agarwal HS, 2014, J THORAC CARDIOV SUR, V148, P609, DOI 10.1016/j.jtcvs.2013.10.031
  2. Barach P, 2008, J THORAC CARDIOV SUR, V136, P1422, DOI 10.1016/j.jtcvs.2008.03.071
  3. Beaton DE, 2000, SPINE, V25, P3186, DOI 10.1097/00007632-200012150-00014
  4. Bellsham-Revell HR, 2019, ECHO RES PRACT, V6, P63, DOI 10.1530/ERP-19-0032
  5. BRASIL, 2017, PLANO NACL ASSISTENC
  6. Carmona F, 2017, BRAZ J CARDIOV SURG, V32, P260, DOI 10.21470/1678-9741-2016-0074
  7. de Leval MR, 2000, J THORAC CARDIOV SUR, V119, P661, DOI 10.1016/S0022-5223(00)70006-7
  8. Gaies MG, 2014, PEDIATR CRIT CARE ME, V15, P529, DOI 10.1097/PCC.0000000000000153
  9. Jacobs JP, 2008, CARDIOL YOUNG, V18, P81, DOI 10.1017/S1047951108003041
  10. Jacobs JP, 2006, ANN THORAC SURG, V81, P1937, DOI 10.1016/j.athoracsur.2005.11.063
  11. Jacques F, 2013, J THORAC CARDIOV SUR, V145, P1465, DOI 10.1016/j.jtcvs.2012.12.065
  12. Jenkins Kathy J, 2004, Semin Thorac Cardiovasc Surg Pediatr Card Surg Annu, V7, P180, DOI 10.1053/j.pcsu.2004.02.009
  13. Jenkins KJ, 2002, J THORAC CARDIOV SUR, V123, P110, DOI 10.1067/mtc.2002.119064
  14. Karamichalis JM, 2010, J THORAC CARDIOV SUR, V139, P962, DOI 10.1016/j.jtcvs.2009.10.011
  15. Larrazabal LA, 2007, ANN THORAC SURG, V83, P179, DOI 10.1016/j.athoracsur.2006.07.031
  16. Malta DC, 2010, CAD SAUDE PUBLICA, V26, P481, DOI 10.1590/S0102-311X2010000300006
  17. Miana LA, 2020, WORLD J PEDIATR CONG, V11, P22, DOI 10.1177/2150135119884916
  18. Nathan M, 2016, J AM COLL CARDIOL, V67, P2696, DOI 10.1016/j.jacc.2016.03.545
  19. Nathan M, 2014, J THORAC CARDIOV SUR, V148, P2208, DOI 10.1016/j.jtcvs.2014.05.076
  20. Nathan M, 2014, J THORAC CARDIOV SUR, V148, P232, DOI 10.1016/j.jtcvs.2013.08.032
  21. Nathan M, 2014, J THORAC CARDIOV SUR, V147, P389, DOI 10.1016/j.jtcvs.2013.07.044
  22. Nathan M, 2013, ANN THORAC SURG, V96, P664, DOI 10.1016/j.athoracsur.2013.04.043
  23. Nathan M, 2012, J THORAC CARDIOV SUR, V144, P1095, DOI 10.1016/j.jtcvs.2012.07.081
  24. Nathan M, 2011, J THORAC CARDIOV SUR, V142, P1098, DOI 10.1016/j.jtcvs.2011.07.003
  25. Nathan N, 2015, SABISTON SPENCER SUR, P2400
  26. Nina Rachel Vilela de Abreu Haickel, 2007, Braz. J. Cardiovasc. Surg., V22, P425, DOI 10.1590/S0102-76382007000400008
  27. Pasquali SK, 2012, ANN THORAC SURG, V94, P573, DOI 10.1016/j.athoracsur.2012.03.065
  28. Pinto VC, 2013, REV BRAS CIR CARDIOV, V28, P256, DOI 10.5935/1678-9741.20130036
  29. Rocha LA, 2018, BRAZ J CARDIOVA SURG, V33, P603, DOI 10.21470/1678-9741-2018-0174
  30. Shimada M, 2020, IMPACT POSTGRADUATE, V84, P495
  31. Shuhaiber J, 2012, J THORAC CARDIOV SUR, V144, P1119, DOI 10.1016/j.jtcvs.2012.02.007
  32. Talwar S, 2018, J CARD CRIT CARE, V2, P025